| Title : XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac Lipotoxicity - Fonseka_2025_Circulation__ |
| Author(s) : Fonseka O , Raja R , Ross C , Gare SR , Zhang J , Hille SS , King K , Ruiz-Velasco A , Kaur N , Chen X , Miller JM , Abouleisa RRE , Ou Q , Zou Z , Zhao X , Sotomayor-Flores C , Frank D , Swanton E , Pool MR , Missaglia S , Tavian D , Schiattarella GG , Wang T , Venetucci L , Pinali C , Rutter MK , Keavney BD , Cartwright EJ , Mohamed TMA , Muller OJ , Liu W |
| Ref : Circulation , : , 2025 |
| Abstract : |
| PubMedSearch : Fonseka_2025_Circulation__ |
| PubMedID: 40130322 |
| Title : XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac Lipotoxicity - Fonseka_2025_Circulation__ |
| Author(s) : Fonseka O , Raja R , Ross C , Gare SR , Zhang J , Hille SS , King K , Ruiz-Velasco A , Kaur N , Chen X , Miller JM , Abouleisa RRE , Ou Q , Zou Z , Zhao X , Sotomayor-Flores C , Frank D , Swanton E , Pool MR , Missaglia S , Tavian D , Schiattarella GG , Wang T , Venetucci L , Pinali C , Rutter MK , Keavney BD , Cartwright EJ , Mohamed TMA , Muller OJ , Liu W |
| Ref : Circulation , : , 2025 |
| Abstract : |
| PubMedSearch : Fonseka_2025_Circulation__ |
| PubMedID: 40130322 |
| Title : XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac Lipotoxicity - Fonseka_2025_Circulation__ |
| Author(s) : Fonseka O , Raja R , Ross C , Gare SR , Zhang J , Hille SS , King K , Ruiz-Velasco A , Kaur N , Chen X , Miller JM , Abouleisa RRE , Ou Q , Zou Z , Zhao X , Sotomayor-Flores C , Frank D , Swanton E , Pool MR , Missaglia S , Tavian D , Schiattarella GG , Wang T , Venetucci L , Pinali C , Rutter MK , Keavney BD , Cartwright EJ , Mohamed TMA , Muller OJ , Liu W |
| Ref : Circulation , : , 2025 |
| Abstract : |
| PubMedSearch : Fonseka_2025_Circulation__ |
| PubMedID: 40130322 |
| Title : Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib - Yeo_2017_PLoS.One_12_e0182115 |
| Author(s) : Yeo A , Li L , Warren L , Aponte J , Fraser D , King K , Johansson K , Barnes A , Macphee C , Davies R , Chissoe S , Tarka E , O'Donoghue ML , White HD , Wallentin L , Waterworth D |
| Ref : PLoS ONE , 12 :e0182115 , 2017 |
| Abstract : |
| PubMedSearch : Yeo_2017_PLoS.One_12_e0182115 |
| PubMedID: 28753643 |
| Gene_locus related to this paper: human-PLA2G7 |
| Title : Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib - Yeo_2017_PLoS.One_12_e0182115 |
| Author(s) : Yeo A , Li L , Warren L , Aponte J , Fraser D , King K , Johansson K , Barnes A , Macphee C , Davies R , Chissoe S , Tarka E , O'Donoghue ML , White HD , Wallentin L , Waterworth D |
| Ref : PLoS ONE , 12 :e0182115 , 2017 |
| Abstract : |
| PubMedSearch : Yeo_2017_PLoS.One_12_e0182115 |
| PubMedID: 28753643 |
| Gene_locus related to this paper: human-PLA2G7 |
| Title : Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib - Yeo_2017_PLoS.One_12_e0182115 |
| Author(s) : Yeo A , Li L , Warren L , Aponte J , Fraser D , King K , Johansson K , Barnes A , Macphee C , Davies R , Chissoe S , Tarka E , O'Donoghue ML , White HD , Wallentin L , Waterworth D |
| Ref : PLoS ONE , 12 :e0182115 , 2017 |
| Abstract : |
| PubMedSearch : Yeo_2017_PLoS.One_12_e0182115 |
| PubMedID: 28753643 |
| Gene_locus related to this paper: human-PLA2G7 |